Home › Funds › NS Partners Ltd › BSX

NS Partners Ltd position in BSX

BOSTON SCIENTIFIC CORP · Health Care

NS Partners Ltd reported holding 289,367 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q2 2026 13F filing — a position valued at US$12.4M, representing 0.53% of its reported portfolio and ranking #48 among its reported holdings. NS Partners Ltd has disclosed BSX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)289.37K sh
Reported value held$12.35M
Portfolio Weight0.53%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How NS Partners Ltd's BSX position evolved

NS Partners Ltd first disclosed a stake in BSX in Q3 2023 at 354,178 shares (US$18.7M). The position peaked in Q2 2025 at 358,651 shares, worth US$38.5M. Across 12 filings, NS Partners Ltd increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 289,367 shares valued at US$12.4M — a reduction of -69,213 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 354.18K $18.70M New
Q4 2023 355.88K $20.57M Hold
Q1 2024 357.88K $24.51M Add
Q2 2024 359.55K $27.69M Hold
Q3 2024 368.53K $30.88M Add
Q4 2024 362.49K $32.38M Reduce
Q1 2025 368.19K $37.14M Add
Q2 2025 358.65K $38.52M Reduce
Q3 2025 358.37K $34.99M Hold
Q4 2025 359.26K $34.26M Hold
Q1 2026 358.58K $22.50M Hold
Q2 2026 289.37K $12.35M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has NS Partners Ltd held BSX?

NS Partners Ltd has disclosed BSX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is NS Partners Ltd's current position in BSX?

As of Q2 2026, NS Partners Ltd holds 289.37K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $12.35M, representing 0.53% of its reported portfolio and ranking #48.

Has NS Partners Ltd been buying or selling BSX?

In the latest 13F filing (Q2 2026), NS Partners Ltd reduced its position in BSX. The position peaked in Q2 2025 at 358.65K shares.

Which other funds hold BSX?

Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.